FAQs for the CITN U01 MEMBER SITE APPLICATION What is the due date for the Letter of Intent? The due for the LOI is October 15th as stated in the NOTICE. The due date in the CTEP site application document (Oct. 8th)

Source URL: ctep.cancer.gov

• Science
• Design of experiments
• Pharmacology
• Food and Drug Administration
• Data
• Clinical trial
• Communications protocol
• Pi
• Clinical research
• Research
• Pharmaceutical industry

CTEP/NCI’s Role in Registration Trials Jeffrey S. Abrams, M.D. Associate Director , Cancer Therapy Evaluation Program Acting Director for Clinical Research Division of Cancer Treatment and Diagnosis National Cancer Ins

Source URL: www.iom.edu

• Chemistry
• Cancer Trials Support Unit
• Cancer and Leukemia Group B
• Bevacizumab
• SWOG
• Eastern Cooperative Oncology Group
• Cetuximab
• American College of Surgeons Oncology Group
• Imatinib
• Medicine
• Cancer organizations
• Oncology

ECOG-ACRIN Cancer Research Group Roster Update Form Steps for Research Personnel: 1. Obtain a Cancer Therapy Evaluation Program (CTEP) identification (ID). A CTEP ID is required for all persons involved in the conduct of

Source URL: ecog-acrin.org

• Computer graphics
• Electrophysiology
• Eastern Cooperative Oncology Group
• Electrocorticography
• Professional certification
• Password
• CTEP
• Portable Document Format
• Medicine
• Cancer organizations
• Biology

CTEP Advisory Committee Membership Finance Advisory Committee (FAC) Business Management and Administration Advisory Committee (BMAAC) Nancy Ostrowski – BMAAC Chairperson, & BMAA Curriculum Writer Business Education/Tec

Source URL: www.mccc.edu

Pharmaceutical Management Branch Cancer Therapy Evaluation Program, DCTD, NCI Policy and Guidelines for INVESTIGATIONAL AGENT RETURNS Policy:

Source URL: ctep.cancer.gov

• Cancer organizations
• Clinical site
• clinical research
• pharmacology

MATERIAL TRANSFER AGREEMENT Provider: Division of Cancer Treatment and Diagnosis, National Cancer Institute Recipient: University

Source URL: ctep.cancer.gov

• Material transfer agreement
• National Institutes of Health
• Health
• Medicine
• Cancer research
• Contract law

PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT

Source URL: ctep.cancer.gov

• National Institutes of Health
• NIH Office of Technology Transfer
• International Statistical Classification of Diseases and Related Health Problems
• Crada
• Research
• Patent
• Title 35 of the United States Code
• Clinical research
• Medicine
• Health
• Cooperative Research and Development Agreement

Pharmaceutical Management Branch Cancer Therapy Evaluation Program, DCTD, NCI Policy and Guidelines for INVESTIGATIONAL AGENT TRANSFERS Policy:

Source URL: ctep.cancer.gov

• Computing
• Agent
• Communications protocol
• Clinical research
• Email
• Data
• Information

NATIONAL INSTITUTES OF HEALTH MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT

Source URL: ctep.cancer.gov

• Research
• Medicine
• NIH Office of Technology Transfer
• National Renewable Energy Laboratory
• Title 35 of the United States Code
• Crada
• Patent
• Invention
• National Institutes of Health
• Science and technology in the United States
• Cooperative Research and Development Agreement

CONFIDENTIAL DISCLOSURE AGREEMENT This Agreement is made by and between the National Cancer Institute, an agency of the United States Government (hereinafter referred to as "NCI"), and (insert

Source URL: ctep.cancer.gov

• Trade secret
• Confidentiality
• Confidential
• Secrecy
• Ethics
• Intellectual property law